NCT04870944 2026-02-24
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
Children's Oncology Group
Phase 1/2 Recruiting
Clinical Trials
5 trialsNCT05498792 2025-04-04
Study of CBL0137 in Combination With Ipilimumab and Nivolumab Therapy in Melanoma
Fox Chase Cancer Center
Phase EARLY_PHASE1 Recruiting
NCT03727789 2024-03-27
CBL0137 in Treating Patients With Advanced Extremity Melanoma or Sarcoma
Roswell Park Cancer Institute
Phase 1 Terminated
NCT01905228 2020-12-10
A Phase 1 Trial of CBL0137 in Patients With Metastatic or Unresectable Advanced Solid Neoplasm
Incuron
Phase 1 Completed
NCT02931110 2020-12-10
Study of IV CBL0137 in Previously Treated Hematological Subjects
Incuron
Phase 1 Terminated